Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2014
12/10/2014CN104195110A 基于人骨髓瘤细胞株及人b淋巴细胞融合制备的全人抗体 Based on human myeloma cell lines and human lymphocyte fusion b prepared fully human antibodies
12/10/2014CN104193825A 一种新型的IgM－IgG聚合物及其聚合方法 A novel IgM-IgG polymer and polymerization process
12/10/2014CN104193824A 人源化抗-C5aR抗体 Humanized anti -C5aR antibody
12/10/2014CN104193823A 一种抗狂犬病病毒特异性人源抗体及应用 A rabies virus-specific human antibodies and application of anti-
12/10/2014CN104193822A 一种狂犬病人免疫球蛋白制备工艺 One kind of human rabies immunoglobulin preparation
12/10/2014CN104193817A 人视黄醇结合蛋白的纯化工艺及其多克隆抗体的制备工艺 Human retinol-binding protein purification process and preparation of polyclonal antibody
12/10/2014CN104193637A 一种特异性克伦特罗半抗原衍生物、克伦特罗人工抗原及其制备方法和应用 One specificity clenbuterol hapten derivatives, clenbuterol artificial antigen and its preparation method and application
12/10/2014CN103304663B 一种鸡源性抗鸡新城疫病毒p蛋白的单链抗体、其制备方法及其用途 One kind of chicken-derived anti-Newcastle disease virus proteins p single chain antibodies, their preparation and their use
12/10/2014CN103214570B 特异于流感病毒h5亚型或者n1亚型的血凝素和神经氨酸酶的单克隆抗体及其应用 H5 specific for influenza virus subtype or subtypes n1 hemagglutinin and neuraminidase monoclonal antibody and its application
12/10/2014CN103209993B 针对赋予对2,4-二氯苯氧乙酸的抗性的酶的单克隆抗体和检测方法 Monoclonal antibodies and detection methods for conferring resistance to 2,4-dichlorophenoxyacetic acid enzyme
12/10/2014CN103204935B 具有改变的细胞信号传导活性的修饰的抗原结合分子 Cells with altered signal transduction activity of modified antigen binding molecule
12/10/2014CN103172735B 抗-系统asc氨基酸转运蛋白2(asct2)抗体 Anti - System asc amino acid transporter 2 (asct2) antibody
12/10/2014CN102884079B 治疗肝炎病毒感染的组合物及方法 Therapeutic compositions and methods for hepatitis virus infection
12/10/2014CN102859001B 用于选择长期生产性细胞的方法 Select the cells in long-term productive method for
12/10/2014CN102827277B 抗人血清白蛋白单链抗体及其碳端连接多肽药物的方法 Methods anti-human serum albumin and C-terminal single-chain antibody peptide drug connection
12/10/2014CN102781962B 双互补位A-β结合多肽 Pairs of complementary bit A-β binding polypeptide
12/10/2014CN102634486B Gpc3单克隆抗体杂交瘤细胞株7d11及其制备方法和应用 Gpc3 7d11 monoclonal antibody hybridoma cell line and its preparation method and application
12/10/2014CN102618545B 与人癌细胞的永生化相关的基因及其应用 Immortalized with human cancer-related gene and its application
12/10/2014CN102574919B 与表皮生长因子受体特异性地结合的抗体 And epidermal growth factor receptor antibody that specifically binds
12/10/2014CN102533910B 免疫毒素的表达和纯化方法 Expression and purification of immunotoxins
12/10/2014CN102300877B 与糖尿病肾病相关的尿及血清的生物标记 And diabetic nephropathy urine and serum biomarkers
12/10/2014CN102268090B 一种暹罗鳄血液提取物及其提取方法和用途 One kind of Siamese crocodile blood extract and extraction methods and uses
12/10/2014CN102015769B 改进的抗-trkb抗体 Improved resistance -trkb antibody
12/10/2014CN101952433B 在疾病的诊断与治疗中的PTHrP，其亚型及其拮抗剂 PTHrP in the diagnosis and treatment of disease, and its subtypes and antagonists
12/10/2014CN101861164B 朊病毒蛋白相关疾病的治疗 Treatment of a disease associated prion protein
12/10/2014CN101842490B 抗原组合物及其在核酸的靶向递送中的应用 Antigen composition and its application in the targeted delivery of nucleic acids
12/10/2014CN101827936B Cdh3肽以及含有cdh3肽的药剂 Cdh3 peptides and peptide drug containing cdh3
12/10/2014CN101784565B 含有亲水性间隔区接头的共轭物 Conjugate comprising a hydrophilic spacer linker
12/10/2014CN101065151B 半胱氨酸改造的抗体和偶联物 Cysteine ​​engineered antibody and conjugate
12/09/2014US8907072 Nucleic acids encoding antibody 137-26 which binds C5 and C5a
12/09/2014US8907069 Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent
12/09/2014US8907068 Anti-IL-20 antibodies and binding partners and methods of using in inflammation
12/09/2014US8907067 Nucleotide and amino acid sequences relating to respiratory diseases and obesity
12/09/2014US8907066 Antibody fusion proteins with a modified FcRn binding site
12/09/2014US8907065 Polypeptides that modulate the interaction between cells of the immune system
12/09/2014US8906864 Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use
12/09/2014US8906863 Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector
12/09/2014US8906857 Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
12/09/2014US8906847 Prodrug comprising a drug linker conjugate
12/09/2014US8906681 Reliable stabilization of N-linked polypeptide native states with enhanced aromatic sequons located in polypeptide tight turns
12/09/2014US8906680 Amino acid sequences directed against chemokines and polypeptides comprising the same for the treatment of chemokine-related diseases and disorders
12/09/2014US8906649 Antibodies binding human collagen II
12/09/2014US8906646 Fed-batch method of making human anti-TNF-alpha antibody
12/09/2014US8906632 Use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma
12/09/2014US8906379 Targeting of glycoprotein therapeutics
12/09/2014US8906378 Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases
12/09/2014US8906377 Stably tethered structures of defined compositions with multiple functions or binding specificities
12/09/2014US8906375 Methods of using antibodies against human IL-22
12/09/2014US8906374 Combination therapy with CD4 lymphocyte depletion and mTOR inhibitors
12/09/2014US8906373 Use of TNF-alpha inhibitor for treatment of psoriasis
12/09/2014US8906372 Purified antibody composition
12/09/2014US8906371 Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors
12/09/2014US8906370 Antibodies against amyloid beta 4 with glycosylation in the variable region
12/09/2014US8906368 Immunoglobulin preparations having increased stability
12/09/2014US8906367 Method of providing disease-specific binding molecules and targets
12/09/2014US8906342 Compositions against cancer antigen LIV-1 and uses thereof
12/04/2014US20140357854 Nucleic acid encoding antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
12/04/2014US20140357853 Nucleic acid encoding antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
12/04/2014US20140357852 Nucleic acid encoding antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
12/04/2014US20140357851 Nucleic acid encoding antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
12/04/2014US20140357850 Nucleic acid encoding antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
12/04/2014US20140357844 Antibodies specific for trop-2 and their uses
12/04/2014US20140357843 Immunoglobulin fc variants
12/04/2014US20140357521 Tools and methods for expression of membrane proteins
12/04/2014US20140356911 Method for Producing Protein
12/04/2014US20140356910 Methods for increasing mannose content of recombinant proteins
12/04/2014US20140356909 Il-17 binding proteins
12/04/2014US20140356908 Binding molecules
12/04/2014US20140356868 Macc1 as a prognostic biomarker for hepatobiliary tumors
12/04/2014US20140356435 Hydrophobic Drug-Delivery Material, Method For Manufacturing Thereof And Methods For Delivery Of A Drug-Delivery Composition
12/04/2014US20140356385 Enzymatic conjugation of antibodies
12/04/2014US20140356384 Erythrocyte-binding therapeutics
12/04/2014US20140356380 Neutralizing Antibodies And Methods Of Use Thereof
12/04/2014US20140356379 Anti-spla2-v antibodies and uses thereof
12/04/2014US20140356377 Compounds for use in boosting coagulation
12/04/2014US20140356376 Anti-wall teichoic antibodies and conjugates
12/04/2014US20140356375 Anti-wall teichoic antibodies and conjugates
12/04/2014US20140356374 Methods for treatment of muscular dystrophy
12/04/2014US20140356372 Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor
12/04/2014US20140356371 Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (pcsk9)
12/04/2014US20140356370 Methods for treating autosomal dominant hypercholesterolemia associated with pcsk9 gain-of-function mutations
12/04/2014US20140356369 Antibodies to human gdf8
12/04/2014US20140356368 Applications of an immune system-released activating agent (israa)
12/04/2014US20140356366 Composition for target membrane protein depletion
12/04/2014US20140356365 Prognostic, screening and treatment methods and agents for treatment of metstasis and inflammation using t54 oncofoetal glycoprotein
12/04/2014US20140356364 Anti-B7-H4 Antibodies and Their Uses
12/04/2014US20140356363 Antigen Binding Proteins that Bind PD-1
12/04/2014US20140356362 Targeted/immunomodulatory fusion proteins and methods for making same
12/04/2014US20140356361 Repeated administration of non-immunosuppressive antigen specific immunotherapeutics
12/04/2014US20140356359 Human growth hormone receptor antagonist antibodies and methods of use thereof
12/04/2014US20140356358 Variant fc-polypeptides with enhanced binding to the neonatal fc receptor
12/04/2014US20140356357 Compounds and methods for treating inflammatory diseases
12/04/2014US20140356356 Use of IL-1 beta Binding Antibodies
12/04/2014US20140356355 Il-17 receptor a antigen binding proteins
12/04/2014US20140356354 Therapy for filovirus infection
12/04/2014US20140356353 Targeted binding agents against b7-h1
12/04/2014US20140356352 COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A CD79b ANTIBODY-DRUG CONJUGATE
12/04/2014US20140356351 Methods of treating progressive forms of multiple sclerosis
12/04/2014US20140356321 Materials and methods for treatment of liver cancer
12/04/2014US20140356287 PLOD2 as a Target of Intervention for Sarcoma Metastasis
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 1494